Quick Takeaways
- Armen Shanafelt has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value is not available.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Armen Shanafelt
- Location
- Indianapolis, IN
- Signature
- /s/ Jessica Fees, as Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Armen Shanafelt and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Aeglea BioTherapeutics, Inc. ().
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Armen Shanafelt
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SYRE | Aeglea BioTherapeutics, Inc. | Director | 07 Jun 2022 | |||
| SURF | Surface Oncology, Inc. | Director, 10%+ Owner | 08 Jun 2022 |
Insider Transactions Reported by Armen Shanafelt:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.